THOUSAND OAKS, Calif., Sept. 20, 2020 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that updated data from the full…
View More Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of MedicineHome »